SCRT1
gene geneOn this page
Also known as DKFZp547F072ZNF898
Summary
SCRT1 (scratch family transcriptional repressor 1, HGNC:15950) is a protein-coding gene on chromosome 8q24.3, encoding Transcriptional repressor scratch 1 (Q9BWW7). Transcriptional repressor that binds E-box motif CAGGTG.
This gene encodes a C2H2-type zinc finger transcriptional repressor that binds to E-box motifs. The encoded protein may promote neural differention and may be involved in cancers with neuroendocrine features.
Source: NCBI Gene 83482 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 40 total
- MANE Select transcript:
NM_031309
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15950 |
| Approved symbol | SCRT1 |
| Name | scratch family transcriptional repressor 1 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp547F072, ZNF898 |
| Ensembl gene | ENSG00000261678 |
| Ensembl biotype | protein_coding |
| OMIM | 605858 |
| Entrez | 83482 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000569446
RefSeq mRNA: 1 — MANE Select: NM_031309
NM_031309
CCDS: CCDS6421
Canonical transcript exons
ENST00000569446 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002604471 | 144330565 | 144334116 |
| ENSE00002619090 | 144336055 | 144336482 |
Expression profiles
Bgee: expression breadth broad, 51 present calls, max score 97.56.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8705 / max 125.0572, expressed in 114 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 95651 | 0.4255 | 88 |
| 95650 | 0.3905 | 81 |
| 95646 | 0.0545 | 35 |
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primary visual cortex | UBERON:0002436 | 97.56 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.49 | gold quality |
| cerebellum | UBERON:0002037 | 94.33 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.32 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.30 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 92.59 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.51 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.97 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.00 | gold quality |
| cortical plate | UBERON:0005343 | 89.34 | gold quality |
| frontal cortex | UBERON:0001870 | 89.21 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 88.29 | gold quality |
| cerebral cortex | UBERON:0000956 | 88.12 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.38 | gold quality |
| prefrontal cortex | UBERON:0000451 | 86.71 | gold quality |
| putamen | UBERON:0001874 | 86.55 | gold quality |
| brain | UBERON:0000955 | 85.16 | gold quality |
| caudate nucleus | UBERON:0001873 | 84.75 | gold quality |
| substantia nigra | UBERON:0002038 | 84.10 | gold quality |
| Ammon’s horn | UBERON:0001954 | 83.65 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.87 | gold quality |
| hypothalamus | UBERON:0001898 | 80.94 | gold quality |
| temporal lobe | UBERON:0001871 | 80.38 | gold quality |
| amygdala | UBERON:0001876 | 80.21 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 72.03 | gold quality |
| pituitary gland | UBERON:0000007 | 64.79 | gold quality |
| adenohypophysis | UBERON:0002196 | 61.03 | gold quality |
| ventricular zone | UBERON:0003053 | 59.26 | gold quality |
| islet of Langerhans | UBERON:0000006 | 58.41 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| SLC6A2 | |
| TUBB3 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0743.1 | SCRT1 | More than 3 adjacent zinc fingers |
| MA0743.2 | SCRT1 | More than 3 adjacent zinc fingers |
| MA0743.3 | SCRT1 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:11274425, PMID:23332764
Upstream regulators (CollecTRI, top): ASCL1, NEUROD2, TCF3
miRNA regulators (miRDB)
88 targeting SCRT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-196A-5P | 100.00 | 68.16 | 684 |
| HSA-MIR-196B-5P | 100.00 | 68.16 | 681 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-6752-5P | 99.59 | 67.32 | 1243 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-4472 | 99.56 | 66.08 | 1478 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-3960 | 99.41 | 66.11 | 96 |
Literature-anchored findings (GeneRIF, showing 3)
- SCRT1 is a novel beta cell transcription factor with insulin regulatory properties. (PMID:33309639)
- Scrt1, a transcriptional regulator of beta-cell proliferation identified by differential chromatin accessibility during islet maturation. (PMID:33888791)
- Long non-coding RNA TCL6 induced by SCRT1 promotes proliferation and metastasis of non-small cell lung cancer through PDK1/AKT signaling. (PMID:37141697)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | scrt1b | ENSDARG00000040214 |
| danio_rerio | scrt1a | ENSDARG00000100821 |
| mus_musculus | Scrt1 | ENSMUSG00000048385 |
| rattus_norvegicus | Scrt1 | ENSRNOG00000025594 |
| drosophila_melanogaster | scrt | FBGN0004880 |
| drosophila_melanogaster | Kah | FBGN0035144 |
| drosophila_melanogaster | CG12605 | FBGN0035481 |
| caenorhabditis_elegans | ces-1 | WBGENE00000468 |
| caenorhabditis_elegans | scrt-1 | WBGENE00016948 |
Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZBTB45 (ENSG00000119574), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF362 (ENSG00000160094), ZNF653 (ENSG00000161914), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), ZNF575 (ENSG00000176472), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB42 (ENSG00000179627), ZBTB20 (ENSG00000181722), ZBTB7C (ENSG00000184828), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397)
Protein
Protein identifiers
Transcriptional repressor scratch 1 — Q9BWW7 (reviewed: Q9BWW7)
Alternative names: Scratch homolog 1 zinc finger protein
All UniProt accessions (1): Q9BWW7
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor that binds E-box motif CAGGTG. Can modulate the action of basic helix-loop-helix (bHLH) transcription factors, critical for neuronal differentiation.
Subunit / interactions. Interacts (via SNAG domain) with LIMD1 (via LIM domains), WTIP (via LIM domains) and AJUBA (via LIM domains).
Subcellular location. Nucleus.
Tissue specificity. Brain specific.
Domain organisation. The N-terminal non zinc-finger region mediates the repressor activity.
Similarity. Belongs to the snail C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_112599* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 |
Pfam: PF00096, PF13912
UniProt features (12 total): zinc finger region 5, compositionally biased region 3, region of interest 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BWW7-F1 | 54.75 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 109 (showing top):
TAATAAT_MIR126, AAGCCAT_MIR135A_MIR135B, GTCTACC_MIR379, GOBP_NEUROGENESIS, CTCTAGA_MIR526C_MIR518F_MIR526A, GOBP_REGULATION_OF_NEURON_MIGRATION, GOBP_NEURON_MIGRATION, GOCC_NUCLEAR_BODY, KIM_WT1_TARGETS_DN, GGGGCCC_MIR296, GSE13522_WT_VS_IFNG_KO_SKIN_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3, MIKKELSEN_MCV6_HCP_WITH_H3K27ME3
GO Biological Process (4): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355), regulation of neuron migration (GO:2001222), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (10): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (2): nuclear body (GO:0016604), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 2 |
| transcription cis-regulatory region binding | 2 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| neuron migration | 1 |
| regulation of cell migration | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1688 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCRT1 | SLC6A2 | P23975 | 810 |
| SCRT1 | ASCL1 | P50553 | 643 |
| SCRT1 | PRRG4 | Q9BZD6 | 415 |
| SCRT1 | GATA3 | P23771 | 410 |
| SCRT1 | SDR16C5 | Q8N3Y7 | 410 |
| SCRT1 | ADCK5 | Q3MIX3 | 401 |
| SCRT1 | FBXL6 | Q8N531 | 397 |
| SCRT1 | CEP41 | Q9BYV8 | 396 |
| SCRT1 | GABARAP | O95166 | 382 |
| SCRT1 | PALM3 | A6NDB9 | 369 |
| SCRT1 | GAD1 | Q99259 | 360 |
| SCRT1 | SLC17A6 | Q9P2U8 | 349 |
| SCRT1 | HP | P00737 | 344 |
| SCRT1 | STMP1 | E0CX11 | 342 |
| SCRT1 | GATAD2B | Q8WXI9 | 335 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NES | SYNM | psi-mi:“MI:0914”(association) | 0.350 |
| SCRT1 | IMPDH1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): IMPDH1 (Affinity Capture-MS), ZNF579 (Affinity Capture-MS), WWP1 (Affinity Capture-MS), PRMT9 (Affinity Capture-MS), SCRT1 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), KLHDC10 (Affinity Capture-MS), VRK3 (Affinity Capture-MS), SCRT1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GUA5, A0A286YF58, A0A494C0N9, A0A494C0Y3, A0A7I2V3R4, A0JNN8, A2ARS0, A2VDX9, A5PJP1, A6NGB7, A8MVW0, C9JTQ0, O14511, O14559, O35392, O35569, O43541, O60548, O70220, P0DPE3, Q08102, Q14V87, Q19A40, Q29RK8, Q2HJ59, Q3TYP4, Q5BLP8, Q5T442, Q63244, Q6F5E0, Q6QNY0, Q6VUP9, Q80WY3, Q80XF7, Q8BQU6, Q8K025, Q8K071, Q8TD94, Q8WY41, Q8WZ71
Diamond homologs: A1L2U9, A2A884, A2ANX9, A7Y7X5, B0X9H6, B0YDH7, B1WAZ8, B1WBU4, E9PW05, E9PZZ1, G5EBU4, O15391, O60315, O62836, O75362, O77459, O95863, P08048, P0CS62, P0CS63, P10925, P15822, P17010, P17012, P20662, P22227, P25490, P28166, P31509, P31629, P36197, P52739, P52746, P56270, P56670, P56671, P60319, P80944, Q00899, Q00900
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
213 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:144336050:CTCA:C | donor_loss | 1.0000 |
| 8:144336051:TCAC:T | donor_loss | 1.0000 |
| 8:144336053:A:AC | donor_gain | 1.0000 |
| 8:144336053:AC:A | donor_gain | 1.0000 |
| 8:144336054:C:CC | donor_gain | 1.0000 |
| 8:144336054:CC:C | donor_gain | 1.0000 |
| 8:144336054:CCTTT:C | donor_gain | 1.0000 |
| 8:144336054:CCT:C | donor_gain | 0.9900 |
| 8:144336054:CCTT:C | donor_gain | 0.9900 |
| 8:144336051:TCACC:T | donor_gain | 0.9500 |
| 8:144334115:CC:C | acceptor_gain | 0.9400 |
| 8:144334116:CC:C | acceptor_gain | 0.9400 |
| 8:144336052:CACCT:C | donor_gain | 0.9400 |
| 8:144336053:ACCTT:A | donor_gain | 0.9100 |
| 8:144336049:GCTCA:G | donor_gain | 0.8700 |
| 8:144336050:CTCAC:C | donor_gain | 0.8700 |
| 8:144336054:C:G | donor_gain | 0.8500 |
| 8:144333131:C:A | donor_gain | 0.8400 |
| 8:144334117:CT:C | acceptor_loss | 0.8000 |
| 8:144334117:C:CC | acceptor_gain | 0.7600 |
| 8:144334124:C:CT | acceptor_gain | 0.7500 |
| 8:144333854:ACG:A | donor_gain | 0.7400 |
| 8:144333855:CGC:C | donor_gain | 0.7400 |
| 8:144333855:CGCCG:C | donor_gain | 0.7300 |
| 8:144334113:TACC:T | acceptor_gain | 0.7300 |
| 8:144333855:CG:C | donor_gain | 0.7100 |
| 8:144334114:ACC:A | acceptor_gain | 0.7100 |
| 8:144334115:CCC:C | acceptor_gain | 0.7100 |
| 8:144334125:G:T | acceptor_gain | 0.7100 |
| 8:144334112:GTACC:G | acceptor_gain | 0.7000 |
AlphaMissense
2227 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:144333266:G:C | H322Q | 1.000 |
| 8:144333266:G:T | H322Q | 1.000 |
| 8:144333268:G:C | H322D | 1.000 |
| 8:144333276:A:G | L319P | 1.000 |
| 8:144333293:G:C | F313L | 1.000 |
| 8:144333293:G:T | F313L | 1.000 |
| 8:144333294:A:C | F313C | 1.000 |
| 8:144333294:A:G | F313S | 1.000 |
| 8:144333295:A:G | F313L | 1.000 |
| 8:144333306:C:G | C309S | 1.000 |
| 8:144333307:A:G | C309R | 1.000 |
| 8:144333307:A:T | C309S | 1.000 |
| 8:144333314:G:C | C306W | 1.000 |
| 8:144333315:C:G | C306S | 1.000 |
| 8:144333316:A:G | C306R | 1.000 |
| 8:144333316:A:T | C306S | 1.000 |
| 8:144333320:G:C | F304L | 1.000 |
| 8:144333320:G:T | F304L | 1.000 |
| 8:144333322:A:G | F304L | 1.000 |
| 8:144333338:A:C | H298Q | 1.000 |
| 8:144333338:A:T | H298Q | 1.000 |
| 8:144333350:G:C | H294Q | 1.000 |
| 8:144333350:G:T | H294Q | 1.000 |
| 8:144333352:G:C | H294D | 1.000 |
| 8:144333352:G:T | H294N | 1.000 |
| 8:144333360:A:G | L291P | 1.000 |
| 8:144333377:G:C | F285L | 1.000 |
| 8:144333377:G:T | F285L | 1.000 |
| 8:144333378:A:G | F285S | 1.000 |
| 8:144333379:A:G | F285L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000210517 (8:144331780 G>A), RS1000368577 (8:144337891 G>A,C), RS1000986647 (8:144336123 G>A), RS1002165871 (8:144332701 C>T), RS1002604547 (8:144330211 G>A), RS1004221611 (8:144337602 G>A), RS1004239772 (8:144334511 T>A,C), RS1004277939 (8:144331254 C>T), RS1004450842 (8:144337243 G>A), RS1004908792 (8:144337382 G>A,T), RS1005897177 (8:144332216 G>A,C), RS1005947562 (8:144332432 C>T), RS1006681891 (8:144335306 G>A,T), RS1007040628 (8:144335161 T>C), RS1007631422 (8:144333244 C>G,T)
Disease associations
OMIM: gene MIM:605858 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002598_30 | Educational attainment | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004784 | self reported educational attainment |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| licochalcone B | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Formaldehyde | increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Thimerosal | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV81 | HEK293 eGFP-SCRT1 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.